International audienceAIMS: In CARE-HF, cardiac resynchronization therapy (CRT) lowered morbidity and mortality in patients with moderate to severe heart failure. We examined whether baseline and follow-up electrocardiographic characteristics might predict long-term outcome. METHODS AND RESULTS: CARE-HF randomly assigned 409 patients to medical therapy (MT) plus CRT, and 404 patients to MT alone. Electrocardiographic measurements were made at baseline during sinus rhythm, and at 3 months during paced or spontaneous rhythm depending on treatment assignment. Favourable outcome was defined as freedom from death, urgent transplantation, or cardiovascular hospitalization. Among patients assigned to CRT, 39% had unfavourable outcomes including 55...
AimsCardiac resynchronization therapy (CRT) improves cardiac function, heart failure symptoms, and p...
ObjectivesThis study was designed to predict the response and prognosis after cardiac resynchronizat...
Cardiac resynchronization therapy (CRT) is now a recommended treatment in patients with severe heart...
Aims Cardiac Resynchronization Therapy (CRT) reduces morbidity and mortality for patients with heart...
ObjectivesThis study was designed to investigate whether selected baseline variables and early respo...
Background: Different electrocardiogram (ECG) findings are known to be independent predictors of cli...
Aims: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in patients with s...
AIMS: Cardiac resynchronization therapy (CRT) is currently considered an important breakthrough i...
International audienceObjectives This study sought to evaluate the impact of baseline PR interval on...
INTRODUCTION: Although strict selection criteria are used to select patients for cardiac resynchroni...
Background: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality for patients w...
Aims: Selection of patients who are viable candidates for cardiac resynchronization therapy (CRT), p...
IntroductionCardiac resynchronization therapy (CRT) is an effective treatment that reduces mortality...
Heart failure affects millions of patients all over the world, and its treatment is a major clinical...
BackgroundHeart failure remains a severe disease with high mortality despite pharmologic treatment a...
AimsCardiac resynchronization therapy (CRT) improves cardiac function, heart failure symptoms, and p...
ObjectivesThis study was designed to predict the response and prognosis after cardiac resynchronizat...
Cardiac resynchronization therapy (CRT) is now a recommended treatment in patients with severe heart...
Aims Cardiac Resynchronization Therapy (CRT) reduces morbidity and mortality for patients with heart...
ObjectivesThis study was designed to investigate whether selected baseline variables and early respo...
Background: Different electrocardiogram (ECG) findings are known to be independent predictors of cli...
Aims: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in patients with s...
AIMS: Cardiac resynchronization therapy (CRT) is currently considered an important breakthrough i...
International audienceObjectives This study sought to evaluate the impact of baseline PR interval on...
INTRODUCTION: Although strict selection criteria are used to select patients for cardiac resynchroni...
Background: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality for patients w...
Aims: Selection of patients who are viable candidates for cardiac resynchronization therapy (CRT), p...
IntroductionCardiac resynchronization therapy (CRT) is an effective treatment that reduces mortality...
Heart failure affects millions of patients all over the world, and its treatment is a major clinical...
BackgroundHeart failure remains a severe disease with high mortality despite pharmologic treatment a...
AimsCardiac resynchronization therapy (CRT) improves cardiac function, heart failure symptoms, and p...
ObjectivesThis study was designed to predict the response and prognosis after cardiac resynchronizat...
Cardiac resynchronization therapy (CRT) is now a recommended treatment in patients with severe heart...